MITOcare GmbH & Co. KG
L-arginine, L-proline, enzymes nattokinase, bromelain, papain, SOD, HAEMATOZYM capsules
L-arginine, L-proline, enzymes nattokinase, bromelain, papain, SOD, HAEMATOZYM capsules
Couldn't load pickup availability
HAEMATOZYM L-arginine, L-proline, enzymes nattokinase, bromelain, papain, SOD capsules 60 pcs
Dietary supplement with vitamin C, L-arginine, L-proline & the enzymes nattokinase, bromelain, papain & SOD
Dosage:
Take 1 gastro-resistant capsule twice daily with about 200 ml of still water - preferably on an empty stomach or at least 60 minutes before a meal.
Notes:
Do not exceed the recommended daily intake. Food supplements should not be used as a substitute for a balanced and varied diet and a healthy lifestyle. Please store the product in a cool, dry place away from light. Keep out of reach of children.
Not recommended for pregnant or breastfeeding women.
If you are taking medication such as blood thinners at the same time, only take this medicine after consulting your doctor.
Ingredients: L-Arginine, DR-Hydroxypropylmethylcellulose (capsule shell), bromelain-rich pineapple extract, L-Proline, papain-rich papaya extract, fermented soybean extract (contains nattokinase), vitamin C-rich acerola extract, cantaloupe extract (rich in superoxide dismutase)
Healthy at its core:
We use only valuable nutrients for our HAEMATOzym – protected in a vegan capsule shell with delayed release. We consciously avoid unnecessary fillers and additives.
This product is vegan and - apart from the soybean extract it contains - produced without allergens
composition | 2 capsules / day | % NRV* |
---|---|---|
Vitamin C (Acerola extract) | 16.00 mg | 20 |
Cantaloupe extract | 20.00 mg | ** |
- contains SOD (superoxide dismutase) | 20.00 IU | ** |
Fermented soybean extract | 100.00 mg | ** |
- contains nattokinase | 2.80 mg | 2000 FU*** |
Papain | 100.00 mg | ** |
Bromelain | 100.00 mg | ** |
L-Arginine | 490.00 mg | ** |
L-proline | 180.00 mg | ** |
* Nutrient reference value for daily intake (EU Regulation No. 1169 / 2011, Annex II)
** No NRV established
*** Fibrinolytic units
Share
